TipRanks
Advertisement
Advertisement

DE:6OP Stock Latest News

OSE Immunotherapeutics Updates Share Capital and Voting Rights Structure
Company AnnouncementsOSE Immunotherapeutics Updates Share Capital and Voting Rights Structure
2d ago
OSE Immunotherapeutics Extends Cash Runway as Tedopi and Lusvertikimab Advance in Late-Stage Trials
PremiumCompany Announcements
OSE Immunotherapeutics Extends Cash Runway as Tedopi and Lusvertikimab Advance in Late-Stage Trials
11d ago
OSE Immunotherapeutics’ Tedopi Lung Cancer Trial Selected for Oral Presentation at ESMO 2026
PremiumCompany Announcements
OSE Immunotherapeutics’ Tedopi Lung Cancer Trial Selected for Oral Presentation at ESMO 2026
16d ago
OSE Immunotherapeutics’ Partner Veloxis Starts Phase 2 Trial of Transplant Drug Pegrizeprument
PremiumCompany Announcements
OSE Immunotherapeutics’ Partner Veloxis Starts Phase 2 Trial of Transplant Drug Pegrizeprument
30d ago
OSE Immunotherapeutics Updates Share Capital and Voting Rights After New Share Issuance
PremiumCompany Announcements
OSE Immunotherapeutics Updates Share Capital and Voting Rights After New Share Issuance
1M ago
OSE Immunotherapeutics Showcases Lead IBD Drug Lusvertikimab in Upcoming KOL Webcast
PremiumCompany AnnouncementsOSE Immunotherapeutics Showcases Lead IBD Drug Lusvertikimab in Upcoming KOL Webcast
1M ago
OSE Immunotherapeutics Updates Share Capital and Voting Rights After New Equity Issuance
Premium
Company Announcements
OSE Immunotherapeutics Updates Share Capital and Voting Rights After New Equity Issuance
1M ago
Ose Immunotherapeutics resumed with a Buy at Kepler Cheuvreux
Premium
The Fly
Ose Immunotherapeutics resumed with a Buy at Kepler Cheuvreux
7M ago
OSE Immunotherapeutics Advances Phase 3 Trial for NSCLC Vaccine
PremiumCompany Announcements
OSE Immunotherapeutics Advances Phase 3 Trial for NSCLC Vaccine
1y ago
6OP
PremiumCompany Announcements
OSE Immunotherapeutics’ Phase 3 Trial: A New Hope for NSCLC Patients
1y ago
PremiumCompany Announcements
OSE Immunotherapeutics Advances in NSCLC Treatment with Phase 3 Trial of OSE2101
1y ago
PremiumCompany Announcements
OSE Immunotherapeutics Advances Cancer Vaccine Trial: Potential Market Impact
1y ago
OSE Immunotherapeutics Advances Phase 3 Trial for Promising Lung Cancer Vaccine
PremiumCompany AnnouncementsOSE Immunotherapeutics Advances Phase 3 Trial for Promising Lung Cancer Vaccine
1y ago
Premium
Company Announcements
OSE Immunotherapeutics Advances Phase 3 Trial for NSCLC Vaccine
1y ago
Premium
Company Announcements
OSE Immunotherapeutics’ Phase I Study Update: Exploring New Cancer Treatments
1y ago
Promising Clinical Trial Results and Strategic Positioning Propel OSE Immunotherapeutics SA to a Buy Rating
PremiumRatingsPromising Clinical Trial Results and Strategic Positioning Propel OSE Immunotherapeutics SA to a Buy Rating
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >